Phenotypic Screen Identifies JAK2 as a Major Regulator of FAT10 Expression

Nava Reznik, Avital Eisenberg-Lerner, Yifat Merbl, Nir London

Research output: Contribution to journalArticlepeer-review


FAT10 is a ubiquitin-like protein suggested to target proteins for proteasomal degradation. It is highly upregulated upon pro-inflammatory cytokines, namely, TNF alpha, IFN gamma, and IL6, and was found to be highly expressed in various epithelial cancers. Evidence suggests that FAT10 is involved in cancer development and may have a pro-tumorigenic role. However, its biological role is still unclear, as well as its biochemical and cellular regulation. To identify pathways underlying FAT10 expression in the context of pro-inflammatory stimulation, which characterizes the cancerous environment, we implemented a phenotypic transcriptional reporter screen with a library of annotated compounds. We identified AZ960, a potent JAK2 inhibitor, which significantly downregulates FAT10 under pro-inflammatory cytokines induction, in an NF kappa B-independent manner. We validated JAK2 as a major regulator of FAT10 expression via knockdown, and we suggest that the transcriptional effects are mediated through pSTAT1/3/5. Overall, we have elucidated a pathway regulating FAT10 transcription and discovered a tool compound to chemically downregulate FAT10 expression, and to further study its biology.
Original languageEnglish
Pages (from-to)2538-2545
Number of pages8
JournalACS Chemical Biology
Issue number12
Early online date3 Dec 2019
StatePublished - 20 Dec 2019


Dive into the research topics of 'Phenotypic Screen Identifies JAK2 as a Major Regulator of FAT10 Expression'. Together they form a unique fingerprint.

Cite this